Amphastar Pharmaceuticals, Inc. (AMPH) Operating income 2016–2025
Amphastar Pharmaceuticals, Inc. (AMPH) annual operating income history from SEC filings — each fiscal year as reported.
$140.4MFY2025 · since FY2016: $15.4M → $140.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $140.4M | -31.7% |
| FY2024 | $205.4M | +4.3% |
| FY2023 | $197.0M | +83.2% |
| FY2022 | $107.5M | +53.8% |
| FY2021 | $69.9M | +538.0% |
| FY2020 | $11.0M | +28187.2% |
| FY2019 | -$39,000 | +99.5% |
| FY2018 | -$8.6M | -579.5% |
| FY2017 | -$1.3M | -108.3% |
| FY2016 | $15.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice